busulfan and cycloserine

busulfan has been researched along with cycloserine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bi, Y; Bongarzone, ER; Hu, P; Kafri, T; Li, Y; Miller, R; Moore, D; Nikolaishvili-Feinberg, N; Pan, D; Sands, MS; Scesa, G1

Reviews

1 review(s) available for busulfan and cycloserine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for busulfan and cycloserine

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.
    Journal of neuroscience research, 2016, Volume: 94, Issue:11

    Topics: Animals; Antigens, CD; Antimetabolites; Brain; Busulfan; Cell Line, Transformed; Cycloserine; Disease Models, Animal; Female; Fibroblasts; Galactosylceramidase; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukodystrophy, Globoid Cell; Receptor, IGF Type 2; Receptors, Somatomedin

2016